As shown in Figure 4, the TCGA database contained a high level of RBM8A mutation in the following types of cancer: bladder cancer, liver cancer, lung cancer, breast cancer, uterine cancer, pancreas, melanoma, head neck, stomach, colorectal cancer, ccRCC, and pRCC. Here, RBM8A is linked to nonpapillary renal cell carcinoma.